Gongxun Zhong

9PUBLICATIONS
50CO-AUTHORS
Biologically active moleculesGlycoconjugatesProteins and peptidesGene and molecular therapyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 01, 2025
Homoharringtonine is highly effective against SARS-CoV-2: a potential first-line defense in future coronavirus epidemics.

Hai-Jun Wen, Hua-Juan Ma, Gong-Xun Zhong

|Jan 03, 2024
Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1.

Ilyas Khan, Sunan Li, Lihong Tao

|Jun 06, 2022
Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies.

Miao-Miao Zhao, Yun Zhu, Li Zhang

|Dec 28, 2021
Author Correction: SARS-CoV-2 uses metabotropic glutamate receptor subtype 2 as an internalization factor to infect cells.

Jinliang Wang, Guan Yang, Xinxin Wang

|Dec 14, 2021
SARS-CoV-2 uses metabotropic glutamate receptor subtype 2 as an internalization factor to infect cells.

Jinliang Wang, Guan Yang, Xinxin Wang

|Oct 22, 2021
Replication, pathogenicity, and transmission of SARS-CoV-2 in minks.

Lei Shuai, Gongxun Zhong, Quan Yuan

Pageof 2

Frequent Collaborators

7 joint publications

Chong Wang

6 joint publications

Zhigao Bu

5 joint publications

Zhiyuan Wen

3 joint publications

Lei Shuai